Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon May 05, 2021 11:43am
52 Views
Post# 33132225

RE:RE:RE:hahaha ... from the mouth of babes

RE:RE:RE:hahaha ... from the mouth of babes
MrMugsy wrote:
Chianchin wrote: Pumping for 7 Years. GUD From $10.75 to now $5.38. How have you being correct? Other than losing fortunes on your own and  for those who followed your advice/pumping. 


Exactly what I wanted to hear from you ... not a clue what I’ve been saying ...

Do you really think this has been bad advice ?
- It’s a long road
- this thing will float for a long time (until it doesn’t anymore)
- been through this before and it took 12 years for the market to notice
- watch the video where Goodman asks for 10 years to build it - pay close attention to the graph

You choose not to listen to that advice and you’d prefer to accuse me of pumping.

I’m sensing a little jealousy - a little disrespect for accuracy.

hahaha !

Love hanging with you kids.  I really do think you’ll eventually learn something from this company ... one day.

What I get to do this time ... is play Goodman a whole different way than I did the first time around.  How often do you get a second chance - at the same thing - with the same CEO.

Blessed !!!

: )




You're still posting lies? Palladin never went down 7 years straight. The market rewarded it as the company progressed. Every time there was a positive press release or daddy fed them new drugs to sell stock grinded higher.

Today is the opposite, every 'positve' press release results in a decling price. Hundreds of millions has been spent just to be kicked off the TSX, underperforming the market by 3/4's and a solid 50% decline for shareholders. That includes you, lol. Feels good? 

What does this mean? What is the market trying to tell us? Basically, market has zero confidence in the CEO and his team. Zero. The market has given him his decade and the result has been a failure so expect this to trade at a discount for a looong time. Office morale must be shell shock lol. Even the financial mainstream media has noticed and is writing about it. Convince me otherwise, pumper.
<< Previous
Bullboard Posts
Next >>